| Structural elucidation of novel degradation impurity and development, validation of a single HPLC method for all putative impurities of Clobetasol propionate in a foam drug product NVDP Ketha, D Kolli, PK Subbappa Journal of Chromatographic Science 62 (5), 444-453, 2024 | 6 | 2024 |
| Using preparative chromatography and NMR/LC-MS/FT-IR, isolation, identification, and characterization of Posaconazole oxidative degradation impurities NVDP Ketha, D Kolli Rasaayan Journal of Chemistry, http://dx.doi.org/10.31788/RJC.2022.1516707, 2022 | 6* | 2022 |
| Assessment of the Water Sorption Capacity of Rifaximin Using the Dynamic Vapor Sorption Technique for Optimization of the Choice of Excipients and the Manufacturing Environment … NVDP Ketha, HR Bapatu, K Ummiti, PK Subbappa, D Kolli Journal of AOAC International 106 (6), 1464-1470, 2023 | 5 | 2023 |
| Flurbiprofen cataplasms: development and validation of in-vitro dissolution methods and evaluation of multimedia dissolution profiles R Nathi, NVDP Ketha, LP Kowtarapu, SK Muchakayala, N Konduru, ... Pharmaceutical Science Advances 1 (2), 100018, 2023 | 3 | 2023 |
| Systematic Selection of Impurities, Development, and Validation of Related Substance Methods for Estradiol and Progesterone in a Combination Drug Product NV Durga Prasad Ketha, D Kolli, PK Subbappa Journal of AOAC International 106 (3), 588-600, 2023 | 2 | 2023 |
| Investigational study of DASATINIB N-oxide impurity in different diluents NVD Prasad Ketha, D Kolli Journal of Chromatographic Science 61 (8), 784-789, 2023 | 1 | 2023 |
| Stable pharmaceutical compositions of clonidine S Mandge, H Gunda, NVDP Ketha, VR Keesara, S Balasubramanian, ... US Patent 12,233,049, 2025 | | 2025 |
| Stable pharmaceutical compositions of cyclophosphamide S Mandge, H Gunda, NVDP Ketha, VR Keesara, B Satheesh, SA Pillai US Patent App. 18/925,887, 2025 | | 2025 |
| Stable pharmaceutical compositions of apixaban S Mandge, VR Keesara, H Gunda, NVDP Ketha, S Balasubramanian, ... US Patent 12,213,972, 2025 | | 2025 |
| Stable pharmaceutical compositions of apixaban SO Dube, NVDP Ketha, SA PILLAI, PK Subbappa US Patent 12,194,028, 2025 | | 2025 |
| Stable pharmaceutical compositions of cyclophosphamide S Mandge, H Gunda, NVDP Ketha, VR Keesara, B Satheesh, SA Pillai US Patent App. 18/441,397, 2024 | | 2024 |
| Stable pharmaceutical compositions of cyclophosphamide S Mandge, H Gunda, NVDP Ketha, VR Keesara, B Satheesh, SA Pillai US Patent 11,931,370, 2024 | | 2024 |
| Stable Pharmaceutical Compositions of Apixaban S Mandge, VR Keesara, H Gunda, NVDP Ketha, S Balasubramanian, ... US Patent App. 18/357,295, 2024 | | 2024 |
| Stable pharmaceutical compositions of hydroxyurea S Mandge, VR Keesara, H Gunda, NVDP Ketha, S Balasubramanian, ... US Patent App. 18/163,811, 2023 | | 2023 |
| Stable pharmaceutical compositions containing estradiol and progesterone for oral administration V Prattipati, VR Keesara, NVDP Ketha, HR Bapatu US Patent App. 17/078,702, 2021 | | 2021 |
| Advance Research in Sciences (ARS) K Ummiti, NR Godi, HR Bapatu, NVDP Ketha, S Pinapala, PK Subbappa | | |
| Pharmaceutical Science Advances R Nathi, NVDP Ketha, LP Kowtarapu, SK Muchakayala, N Konduru, ... | | |
Dr Deepti KolliAssistant Professor, Dept.of Chemistry,KL UniversityVerified email at kluniversity.in